CGN
中广核
CGN (中广核, China General Nuclear Power Group) is a state-owned nuclear energy enterprise. Per a 2023 FreeS Capital report, CGN operates a medium-energy cyclotron in Mianyang, Sichuan for producing medical isotopes, part of China's broader push to build nuclear medicine supply chains . A 2024 Linear Capital announcement also notes that Yuansuan Technology's CAE simulation software has been deployed at CGN alongside other major state power groups, reflecting CGN's role as an industrial end-user for domestic software substitution . In overseas expansion, CGN was named among Chinese new-energy and infrastructure firms with public partnerships in Saudi Arabia, per a 2023 暗涌Waves piece .
AI-generated — may contain errors, please verify.
Coverage
Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
Trekking to Riyadh
Opportunity, wealth, and a surging tide of people.
Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
